Amgen to invest $650m in US manufacturing network expansion
The investment aims to scale up the production of drugs at the company’s Juncos’ biologics production facility.
29 September 2025
29 September 2025
The investment aims to scale up the production of drugs at the company’s Juncos’ biologics production facility.
This year’s Life Sciences Baltics conference in Vilnius, Lithuania, amply demonstrated the maturation and growing value proposition of life sciences in the country and across the wider Baltics region.
AstraZeneca joins the DTC model trend in the US after Trump urged drugmakers to slash drug prices.
The decision to broaden the antibody’s indication was based on clinical efficacy and safety data from six children.
Jeff Miglicco, CEO & Co-Founder of PureWay highlights that dangers of medical waste's role in counterfeit weight-loss injectables.
The 100% rate on imported, branded pharma products will not apply to drugmakers constructing manufacturing facilities in the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.